v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 14,815 $ 14,063
Premium and trade receivables 22,436 19,713
Short-term investments 2,472 2,622
Other current assets 1,565 1,601
Total current assets 41,288 37,999
Long-term investments 18,268 17,429
Restricted deposits 1,409 1,390
Property, software and equipment, net 2,044 2,067
Goodwill 17,558 17,558
Intangible assets, net 5,236 5,409
Other long-term assets 1,241 593
Total assets 87,044 82,445
Current liabilities:    
Medical claims liability 19,911 18,308
Accounts payable and accrued expenses 13,948 13,174
Return of premium payable 2,403 2,008
Unearned revenue 869 661
Current portion of long-term debt 12 110
Total current liabilities 37,143 34,261
Long-term debt 18,308 18,423
Deferred tax liability 708 684
Other long-term liabilities 2,866 2,567
Total liabilities 59,025 55,935
Commitments and contingencies
Redeemable noncontrolling interests 12 10
Stockholders' equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2025 and December 31, 2024 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 622,511 issued and 497,518 outstanding at March 31, 2025, and 620,195 issued and 495,907 outstanding at December 31, 2024 1 1
Additional paid-in capital 20,631 20,562
Accumulated other comprehensive (loss) (337) (504)
Retained earnings 16,659 15,348
Treasury stock, at cost (124,993 and 124,288 shares, respectively) (9,038) (8,997)
Total Centene stockholders' equity 27,916 26,410
Nonredeemable noncontrolling interest 91 90
Total stockholders' equity 28,007 26,500
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 87,044 $ 82,445